NasdaqGS:UTMD

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

Utah Medical Products, Inc. manufactures and distributes medical devices for the healthcare industry in the United States, Europe, and internationally. More Details

Rewards

Trading at 38.7% below our estimate of its fair value

Risk Analysis

No risks detected for UTMD from our risk checks.


Snowflake Analysis

Flawless balance sheet and good value.


Similar Companies

Share Price & News

How has Utah Medical Products's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: UTMD has not had significant price volatility in the past 3 months.


Market Performance


7 Day Return

-0.6%

UTMD

-1.7%

US Medical Equipment

-0.8%

US Market


1 Year Return

-15.5%

UTMD

16.5%

US Medical Equipment

13.8%

US Market

Return vs Industry: UTMD underperformed the US Medical Equipment industry which returned 16.5% over the past year.

Return vs Market: UTMD underperformed the US Market which returned 13.8% over the past year.


Shareholder returns

UTMDIndustryMarket
7 Day-0.6%-1.7%-0.8%
30 Day-3.2%-3.3%-5.0%
90 Day-10.0%13.4%10.1%
1 Year-14.5%-15.5%17.5%16.5%16.4%13.8%
3 Year14.4%10.3%70.0%65.6%36.9%27.8%
5 Year64.0%53.0%139.5%121.3%85.0%64.2%

Price Volatility Vs. Market

How volatile is Utah Medical Products's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Utah Medical Products undervalued compared to its fair value and its price relative to the market?

38.7%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: UTMD ($81.1) is trading below our estimate of fair value ($132.38)

Significantly Below Fair Value: UTMD is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: UTMD is good value based on its PE Ratio (24x) compared to the US Medical Equipment industry average (49.1x).

PE vs Market: UTMD is poor value based on its PE Ratio (24x) compared to the US market (17.6x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate UTMD's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: UTMD is good value based on its PB Ratio (3.1x) compared to the US Medical Equipment industry average (3.9x).


Next Steps

Future Growth

How is Utah Medical Products forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

24.4%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Utah Medical Products has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Utah Medical Products performed over the past 5 years?

5.4%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: UTMD has high quality earnings.

Growing Profit Margin: UTMD's current net profit margins (28.4%) are lower than last year (39.3%).


Past Earnings Growth Analysis

Earnings Trend: UTMD's earnings have grown by 5.4% per year over the past 5 years.

Accelerating Growth: UTMD's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: UTMD had negative earnings growth (-25.4%) over the past year, making it difficult to compare to the Medical Equipment industry average (1.8%).


Return on Equity

High ROE: UTMD's Return on Equity (13.1%) is considered low.


Next Steps

Financial Health

How is Utah Medical Products's financial position?


Financial Position Analysis

Short Term Liabilities: UTMD's short term assets ($53.1M) exceed its short term liabilities ($3.2M).

Long Term Liabilities: UTMD's short term assets ($53.1M) exceed its long term liabilities ($5.0M).


Debt to Equity History and Analysis

Debt Level: UTMD is debt free.

Reducing Debt: UTMD had no debt 5 years ago.

Debt Coverage: UTMD has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: UTMD has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Next Steps

Dividend

What is Utah Medical Products's current dividend yield, its reliability and sustainability?

1.38%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: UTMD's dividend (1.38%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.72%).

High Dividend: UTMD's dividend (1.38%) is low compared to the top 25% of dividend payers in the US market (4.94%).


Stability and Growth of Payments

Stable Dividend: UTMD's dividends per share have been stable in the past 10 years.

Growing Dividend: UTMD's dividend payments have increased over the past 10 years.


Current Payout to Shareholders

Dividend Coverage: With its reasonably low payout ratio (32.9%), UTMD's dividend payments are well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

23.2yrs

Average board tenure


CEO

Kevin Cornwell (73 yo)

27.75yrs

Tenure

US$474,120

Compensation

Mr. Kevin L. Cornwell has been the Chairman of the Board at Utah Medical Products Inc. since 1996 and its President and Chief Executive Officer since December 1992. Mr. Cornwell has been Secretary of Utah ...


CEO Compensation Analysis

Compensation vs Market: Kevin's total compensation ($USD474.12K) is below average for companies of similar size in the US market ($USD1.36M).

Compensation vs Earnings: Kevin's compensation has been consistent with company performance over the past year.


Board Members

NamePositionTenureCompensationOwnership
Kevin Cornwell
Chairman27.75yrsUS$474.12k5.23%
$ 15.4m
Paul Richins
Director22.67yrsUS$26.00k0.64%
$ 1.9m
Ernst Hoyer
Independent Lead Directorno dataUS$33.00k0.27%
$ 811.0k
Barbara Payne
Independent Director23.67yrsUS$26.00k0.37%
$ 1.1m
James Beeson
Independent Director13.58yrsUS$26.00k0.36%
$ 1.1m

23.2yrs

Average Tenure

73yo

Average Age

Experienced Board: UTMD's board of directors are seasoned and experienced ( 23.2 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Utah Medical Products, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Utah Medical Products, Inc.
  • Ticker: UTMD
  • Exchange: NasdaqGS
  • Founded: 1978
  • Industry: Health Care Supplies
  • Sector: Healthcare
  • Market Cap: US$295.459m
  • Shares outstanding: 3.64m
  • Website: https://www.utahmed.com

Number of Employees


Location

  • Utah Medical Products, Inc.
  • 7043 South 300 West
  • Midvale
  • Utah
  • 84047-1048
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
UTMDNasdaqGS (Nasdaq Global Select)YesCommon StockUSUSDDec 1982

Biography

Utah Medical Products, Inc. manufactures and distributes medical devices for the healthcare industry in the United States, Europe, and internationally. The company offers fetal monitoring accessories, vacu ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/09/27 05:43
End of Day Share Price2020/09/25 00:00
Earnings2020/06/30
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.